Information  X 
Enter a valid email address

Reckitt Benckiser Gp (RB.)

  Print          Annual reports

Friday 26 March, 2021

Reckitt Benckiser Gp

Director/PDMR Shareholding

RNS Number : 6752T
Reckitt Benckiser Group PLC
26 March 2021
 

26 March 2021

 

RECKITT BENCKISER GROUP PLC

 

DIRECTOR/PDMR SHAREHOLDINGS

 

Reckitt Benckiser Group plc (the "Company") announces the following changes in the interests of Directors and Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

 

1. Vesting of Replacement Award

 

As previously announced on 6 August 2019, Laxman Narasimhan, Chief Executive Officer, was granted a target award of 48,410 Shares (with a maximum award of 175% of target). This award also accrues dividend equivalents. The award was made to compensate for remuneration arrangements forfeited by Mr Narasimhan on leaving his previous employer, PepsiCo and was based on PepsiCo Inc.'s performance over the three-year period which ended in December 2020. Following the publication of PepsiCo's proxy report, on 24 March 2021 the vesting of Mr Narasimhan's award was confirmed at 52.60% of the target amount of 48,410 Shares, which equated to 25,463 Shares, plus dividend equivalents amounting to 891 Shares. The balance of the Shares has lapsed.

 

On 25 March 2021, 26,354 Shares were released to Mr Narasimhan. He retained the net balance of 13,948 Shares, following the sale of 12,406 Shares to settle resultant tax and social security liabilities. Following this transaction, Mr Narasimhan's beneficial holding has increased to 56,052 Shares, representing 0.00786% of the total voting rights of the Company.

 

  Full details of this award were set out on page 125 of our 2019 Annual Report and Accounts.

 

2. Grant of Deferred Bonus Share Awards

 

On 25 March 2021, the grant of conditional share awards was made under the Reckitt Benckiser Group Deferred Bonus Plan ("DBP") to the Directors and PDMRs listed below:

 

 

Name

Director/PDMR

Number of Shares under award

L axman Narasimhan

Director

21,124

Jeff Carr

Director

9,163

Kris Licht

PDMR

8,059

 

 

The following notifications are made in accordance with DTR 3.1.2-A, incorporating article 19(1) of the Market Abuse Regulation.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Laxman Narasimhan

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/
Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

 

GB00B24CGK77

b)

Nature of the transaction

Vesting of replacement share awards in relation to former employment with PepsiCo, Inc.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

26,354

 

d)

Aggregated information

Aggregated volume

Price

 

N/A

 

e)

Date of the transaction

2021-03-25

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

GB00B24CGK77 - ID code for ordinary shares

b)

Nature of the transaction

Sale of shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£64.5262

12,406

 

d)

Aggregated information

Aggregated volume

Price

Aggregate Price

Aggregate Volume

Aggregate Total

£64.5262

12,406

£800,512.04

 

e)

Date of the transaction

2021-03-25

f)

Place of the transaction

London Stock Exchange, Main Market - XLON

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

 

GB00B24CGK77

b)

Nature of the transaction

Grant of conditional share awards for nil consideration under the Reckitt Benckiser Group Deferred Bonus Plan  

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

21,124

 

d)

Aggregated information

Aggregated volume

Price

 

N/A

 

e)

Date of the transaction

2021-03-25

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jeff Carr

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/
Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

 

GB00B24CGK77

b)

Nature of the transaction

Grant of conditional share awards for nil consideration under the Reckitt Benckiser Group Deferred Bonus Plan  

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

9,163

 

d)

Aggregated information

Aggregated volume

Price

 

N/A

 

e)

Date of the transaction

2021-03-25

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kris Licht

2

Reason for the notification

a)

Position/status

President Health and Chief Customer Officer

b)

Initial notification/
Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc

 

GB00B24CGK77

b)

Nature of the transaction

Grant of conditional share awards for nil consideration under the Reckitt Benckiser Group Deferred Bonus Plan  

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

8,059

 

d)

Aggregated information

Aggregated volume

Price

N/A

e)

Date of the transaction

2021-03-25

f)

Place of the transaction

Outside a trading venue

 

 

 

For further Information:
Rupert Bondy

Company Secretary

Tel +44 (0) 1753 217 800

 

John Dawson

SVP, Investor Relations

Tel. +44 (0) 1753 217 800

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

About Reckitt:  

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. W e believe that  access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of more than 43,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at  www.reckitt.com

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDGDXRGDDGBL

a d v e r t i s e m e n t